800,000 dengue vaccine recipients studied in vietnam
NCT ID NCT07501793
First seen Apr 05, 2026 · Last updated May 16, 2026 · Updated 3 times
Summary
This study looks at the health records of up to 800,000 people who received the TAK-003 (Qdenga) dengue vaccine at VNVC centers in Vietnam. Researchers want to describe who got the vaccine, including their age, sex, and where they live. No new tests or visits are needed—only existing data is used.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DENGUE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Vietnam Vaccine Joint Stock Company
Ho Chi Minh City, Ho Chi Minh, 700000, Vietnam
Conditions
Explore the condition pages connected to this study.